Michael D Parker

Title: Michael D Parker: Innovator in Bovine Coronavirus Research

Introduction

Michael D Parker is a notable inventor based in Saskatoon, Canada. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for bovine coronavirus. With a total of 3 patents, his work has had a substantial impact on animal health.

Latest Patents

Parker's latest patents include groundbreaking research on recombinant bovine coronavirus E2 and E3 polypeptides and vaccines. His patents detail nucleic acid sequences encoding the Bovine Coronavirus E2 (or BCV S) and E3 (or BCV HE) structural glycoproteins. These sequences are crucial for producing the proteins through recombinant expression in mammalian or insect cells. The E2 and E3 proteins, or their antigenic fragments, serve as essential components for Bovine Coronavirus vaccines and treatment methods. Additionally, he has developed DNA encoding bovine coronavirus polypeptides E2 and E3, which are vital for producing effective vaccines.

Career Highlights

Throughout his career, Parker has worked with esteemed organizations such as the Veterinary Infectious Disease Organization and the University of Saskatchewan. His research has focused on enhancing the understanding and treatment of bovine coronavirus, contributing to improved health outcomes in livestock.

Collaborations

Parker has collaborated with notable colleagues in his field, including Graham J Cox and Lorne A Babiuk. These partnerships have fostered innovation and advancement in veterinary infectious disease research.

Conclusion

Michael D Parker's contributions to bovine coronavirus research and vaccine development highlight his role as a key innovator in veterinary medicine. His patents and collaborations continue to influence the field positively.